The estimated Net Worth of Daniel Raskas is at least $19.2 Milione dollars as of 25 July 2024. Mr. Raskas owns over 14,507 units of Envista Corp stock worth over $416,216 and over the last 19 years he sold NVST stock worth over $18,725,922. In addition, he makes $58,425 as Director at Envista Corp.
Sign up
Mr. Raskas NVST stock SEC Form 4 insiders trading
Daniel has made over 25 trades of the Envista Corp stock since 2009, according to the Form 4 filled with the SEC. Most recently he sold 14,507 units of NVST stock worth $3,924,289 on 25 July 2024.
The largest trade he's ever made was exercising 56,000 units of Envista Corp stock on 20 February 2015 worth over $1,720,880. On average, Daniel trades about 3,674 units every 41 days since 2005. As of 25 July 2024 he still owns at least 23,595 units of Envista Corp stock.
You can see the complete history of Mr. Raskas stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Daniel Raskas biography
Daniel A. Raskas serves as Director of the Company. Mr. Raskas has served as Senior Vice President - Corporate Development of Danaher Corporation since 2010 after serving as Vice President - Corporate Development from 2004, when he joined Danaher, until 2010. Prior to joining Danaher, Mr. Raskas was a Managing Director for Thayer Capital Partners, a private equity investment firm. Mr. Raskas’ corporate development and private equity experience give him particular insight into acquisition strategy, which represents a key strategic opportunity for us.
What is the salary of Daniel Raskas?
As the Director of Envista Corp, the total compensation of Daniel Raskas at Envista Corp is $58,425. There are 12 executives at Envista Corp getting paid more, with Amir Aghdaei having the highest compensation of $7,377,910.
How old is Daniel Raskas?
Daniel Raskas is 53, he's been the Director of Envista Corp since 2019. There are 8 older and 9 younger executives at Envista Corp. The oldest executive at Envista Holdings Corp is Amir Aghdaei, 62, who is the President, Chief Executive Officer, Director.
What's Daniel Raskas's mailing address?
Daniel's mailing address filed with the SEC is 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON, DC, 20037.
Insiders trading at Envista Corp
Over the last 5 years, insiders at Envista Corp have traded over $35,099,063 worth of Envista Corp stock and bought 101,717 units worth $1,939,832 . The most active insiders traders include Corp /De/ Danaher, Vivek Jain e Wendy Carruthers. On average, Envista Corp executives and independent directors trade stock every 31 days with the average trade being worth of $320,413. The most recent stock trade was executed by Paul A Keel on 13 August 2024, trading 30,000 units of NVST stock currently worth $506,100.
What does Envista Corp do?
we know that dental professionals do more than create healthy, beautiful smiles—they create confidence. to achieve their goals, they need a champion. they need someone who will be there for them, side by side and end to end. at envista, we are uniquely positioned to be this champion. our differentiated combination of continuous improvement, a bias toward action and innovation, and a deep respect for the professionals we serve embolden us to champion dental professionals like no one else can. our comprehensive product portfolio covers an estimated 90% of dentists’ clinical needs for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. we believe true champions lift each other up, and we are looking for new champions to join our team. if you believe, champions do more than win, they stand for something bigger, you can build a meaningful career at envista. if you believe champions work to be their best, help others be theirs, sho
What does Envista Corp's logo look like?
Complete history of Mr. Raskas stock trades at Danaher e Envista Corp
Envista Corp executives and stock owners
Envista Corp executives and other stock owners filed with the SEC include:
-
Amir Aghdaei,
President, Chief Executive Officer, Director -
Amir Aghdaei,
Pres, CEO & Director -
Patrik Eriksson,
Senior Vice President -
Curt Bludworth,
Chief Human Resource Officer, Senior Vice President -
Howard Yu,
Chief Financial Officer, Senior Vice President -
Patrik Eriksson,
Sr. VP & Pres of Nobel Biocare -
Howard H. Yu,
Sr. VP & CFO -
Mark E. Nance,
Sr. VP, Gen. Counsel & Sec. -
Jean-Claude E. Kyrillos,
Sr. VP and Pres of Imaging & DTX -
Scott Huennekens,
Independent Chairman of the Board -
Christine Tsingos,
Independent Director -
Wendy Carruthers,
Independent Director -
Kieran Gallahue,
Independent Director -
Daniel Raskas,
Director -
John Bedford,
Vice President - Investor Relations -
Gayle Sheppard,
Independent Director -
Vivek Jain,
Independent Director -
Mischa Reis,
Senior Vice President - Strategy and Corporate Development -
Jean-Claude Kyrillos,
Senior Vice President and President of the KaVo Kerr Business -
Jeffrey Kappler,
Senior Vice President -
Mark Nance,
Senior Vice President, General Counsel, Secretary -
Curt W. Bludworth,
Sr. VP & Chief HR Officer -
Mischa M. Reis,
Sr. VP of Strategy & Corp. Devel. -
Juan Arbona,
Chief Compliance Officer -
John C. Moten,
VP of Investor Relations -
Kari-Lyn Moore,
VP & Chief Accounting Officer -
Robert Befidi,
President, Diagnostics -
Paul A Keel,
Chief Executive Officer -
Corp /De/ Danaher,
10% owner -
William K Daniel,
Director -
Hans Geiselhoeringer,
SENIOR VICE PRESIDENT -
Eric Conley,
SVP, Orthodontics -
Barbara B. Hulit,
Director -
Stephen Keller,
Principal Financial Officer -
Faez C Kaabi,
Chief Accounting Officer -
Eric D. Hammes,
Chief Financial Officer